Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for recovery quality after painless colonoscopy in elderly patients
ChiCTR2500095232Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Colorectal disease comparing A Group (Remimazolam) with B Group (Propofol) (2 arms). Primary endpoint: Postoperative quality of recovery-15 scale score. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
Colorectal disease
Beyond the preview
Go deeper on ChiCTR2500095232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095232.